S. Charleson

5.6k total citations
51 papers, 2.7k citations indexed

About

S. Charleson is a scholar working on Physiology, Pharmacology and Organic Chemistry. According to data from OpenAlex, S. Charleson has authored 51 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 16 papers in Pharmacology and 13 papers in Organic Chemistry. Recurrent topics in S. Charleson's work include Asthma and respiratory diseases (22 papers), Inflammatory mediators and NSAID effects (14 papers) and Synthesis and biological activity (9 papers). S. Charleson is often cited by papers focused on Asthma and respiratory diseases (22 papers), Inflammatory mediators and NSAID effects (14 papers) and Synthesis and biological activity (9 papers). S. Charleson collaborates with scholars based in Canada, United States and Denmark. S. Charleson's co-authors include Joseph A. Mancini, Denis Riendeau, Elizabeth Wong, Philip J. Vickers, Diane Ethier, Jillian F. Evans, Roger L. Hudgin, A. W. Ford‐Hutchinson, Paul L. Wood and Stacia Kargman and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Gastroenterology.

In The Last Decade

S. Charleson

50 papers receiving 2.6k citations

Peers

Countries citing papers authored by S. Charleson

Since Specialization

Citations

This map shows the geographic impact of S. Charleson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Charleson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Charleson more than expected).

Fields of papers citing papers by S. Charleson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Charleson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Charleson. The network helps show where S. Charleson may publish in the future.

Co-authorship network of co-authors of S. Charleson

This figure shows the co-authorship network connecting the top 25 collaborators of S. Charleson. A scholar is included among the top collaborators of S. Charleson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Charleson. S. Charleson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Denis Deschênes, Daniel Dubé, (unknown), Michel Gallant, Dwight Macdonald, (unknown), Hélène Perrier, S. Charleson, Zheng Huang, France Laliberté, Susana Liu, Joseph A. Mancini, P. Masson, Myriam Salem, Angela Styhler, Yves Girard	3
2	Pyridazinones as selective cyclooxygenase-2 inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Chun Sing Li, Christine Brideau, Chi Chung Chan, Chantal Savoie, David Claveau, S. Charleson, Robert J. Gordon, Gillian Greig, Jacques Yves Gauthier, Cheuk K. Lau, Denis Riendeau, Michel Thérien, Elizabeth Wong, Petpiboon Prasit	67
3	3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility 2003 ·Bioorganic & Medicinal Chemistry Letters ·W. Cameron Black, Christine Brideau, Chi-Chung Chan, S. Charleson, Wanda Cromlish, Robert J. Gordon, Erich L. Grimm, Gregory Hughes, Serge Léger, (unknown), Denis Riendeau, Michel Thérien, Zhaoyin Wang, (unknown), Petpiboon Prasit	29
4	Synthesis and biological evaluation of 3-heteroaryloxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·Cheuk K. Lau, Christine Brideau, Chi Chung Chan, S. Charleson, Wanda Cromlish, Diane Ethier, Jacques Yves Gauthier, Robert J. Gordon, Jocelyne Guay, Stacia Kargman, (unknown), Petpiboon Prasit, (unknown), Michel Thérien, Denise M. Visco, Lijing Xu	25
5	Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·Richard Frenette, John H. Hutchinson, Serge Léger, Michel Thérien, Christine Brideau, Chi Chung Chan, S. Charleson, Diane Ethier, Jocelyne Guay, Tom R. Jones, M. McAuliffe, H. Piechuta, (unknown), Philip Tagari, Yves Girard	11
6	Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class 1999 ·Bioorganic & Medicinal Chemistry Letters ·Nathalie Ouimet, Chi-Chung Chan, S. Charleson, David Claveau, Robert J. Gordon, Daniel Guay, (unknown), Marc Ouellet, D. Percival, Denis Riendeau, Elizabeth Wong, Robert Zamboni, Petpiboon Prasit	20
7	A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), W. Cameron Black, Christine Brideau, (unknown), S. Charleson, Wanda Cromlish, David Claveau, (unknown), Robert J. Gordon, Gillian Greig, Erich L. Grimm, Jocelyne Guay, Cheuk K. Lau, Denis Riendeau, Michel Thérien, Denise M. Visco, Elizabeth Wong, Lijing Xu, Petpiboon Prasit	23
8	SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor 1999 ·Bioorganic & Medicinal Chemistry Letters ·Y. LEBLANC, Patrick Roy, S. Boyce, Christine Brideau, Chi-Chung Chan, S. Charleson, Robert J. Gordon, Erich L. Grimm, Jocelyne Guay, Serge Léger, (unknown), Denis Riendeau, Denise M. Visco, (unknown), J.K. Webb, Lijing Xu, Petpiboon Prasit	38
9	Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells 1997 ·Inflammation Research ·Elizabeth Wong, Carmela DeLuca, (unknown), S. Charleson, Wanda Cromlish, D. Denis, Stacia Kargman, Brian P. Kennedy, Marc Ouellet, Kathryn Skorey, Gary P. O’Neill, Philip J. Vickers, Denis Riendeau	34
10	Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts 1996 ·Gastroenterology ·Stacia Kargman, S. Charleson, Mark E. Cartwright, J. Frank, Denis Riendeau, Joseph A. Mancini, Jillian F. Evans, Gary P. O’Neill	400
11	Thiopyranol[2,3,4-c,d]indoles as Inhibitors of 5-Lipoxygenase, 5-Lipoxygenase-Activating Protein, and Leukotriene C4 Synthase 1995 ·Journal of Medicinal Chemistry ·John H. Hutchinson, S. Charleson, Jillian F. Evans, Jean‐Pierre Falgueyret, Karst Hoogsteen, Thomas R. Jones, Stacia Kargman, Dwight Macdonald, C. S. McFarlane	34
12	The binding of leukotriene biosynthesis inhibitors to site-directed mutants of human 5-lipoxygenase-activating protein 1994 ·Life Sciences ·Joseph A. Mancini, Marc G. Coppolino, (unknown), S. Charleson, Philip J. Vickers	13
13	Structural requirements for the binding of fatty acids to 5-lipoxygenase-activating protein 1994 ·European Journal of Pharmacology Molecular Pharmacology ·S. Charleson, Jilly F. Evans, Serge Léger, Hélène Perrier, Petpiboon Prasit, Zhaoyin Wang, Philip J. Vickers	22
14	A new class of leukotriene biosynthesis inhibitor: the development of MK-0591. 1993 ·PubMed ·Peppi Prasit, Michel Belley, (unknown), Christine Brideau, Catherine B. Chan, S. Charleson, (unknown), Richard Frenette, (unknown), (unknown)	21
15	5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. 1993 ·The Journal of Experimental Medicine ·John Woods, Jilly F. Evans, Diane Ethier, S Scott, Philip J. Vickers, (unknown), Jeffrey A. Heibein, S. Charleson, Irwin Singer	341
16	5‐lipoxygenase‐activating protein is an arachidonate binding protein 1993 ·FEBS Letters ·Joseph A. Mancini, Mark Abramovitz, Martha E. Cox, Elizabeth Wong, S. Charleson, Hélène Perrier, Zhaoyin Wang, (unknown), Philip J. Vickers	179
17	Cross-species comparison of 5-lipoxygenase-activating protein. 1992 ·Molecular Pharmacology ·Philip J. Vickers, Gary P. O’Neill, Joseph A. Mancini, S. Charleson, Mark Abramovitz	12
18	Urinary leukotriene E4 levels during early and late asthmatic responses 1990 ·Journal of Allergy and Clinical Immunology ·(unknown), Joshua Rokach, Malo Jl, Diane Ethier, André Cartier, Yves Girard, S. Charleson, Paul M. O’Byrne	158
19	5-Lipoxygenase inhibitors and allergic conjunctivitis reactions in the guinea-pig 1987 ·European Journal of Pharmacology ·D. Garceau, Anthony W. Ford‐Hutchinson, S. Charleson	13
20	Leukotriene B3, leukotriene B4 and leukotriene B5; Binding to leukotriene B4 receptors on rat and human leukocyte membranes 1986 ·Prostaglandins ·S. Charleson, Jillian F. Evans, Robert Zamboni, Yves Leblanc, Brian J. Fitzsimmons, Claire Leveillé, Philippe Dupuis, Anthony W. Ford‐Hutchinson	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact